🎉 M&A multiples are live!
Check it out!

Sido Muncul Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sido Muncul and similar public comparables like Mega Lifesciences, Abbott India, and Procter & Gamble Health.

Sido Muncul Overview

About Sido Muncul

PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine and supplement, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.


Founded

1975

HQ

Indonesia
Employees

4.4K+

Financials

LTM Revenue $246M

LTM EBITDA $94.6M

EV

$976M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Sido Muncul Financials

Sido Muncul has a last 12-month revenue of $246M and a last 12-month EBITDA of $94.6M.

In the most recent fiscal year, Sido Muncul achieved revenue of $235M and an EBITDA of $91.5M.

Sido Muncul expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Sido Muncul valuation multiples based on analyst estimates

Sido Muncul P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $214M $235M XXX XXX XXX
Gross Profit $130M $121M XXX XXX XXX
Gross Margin 61% 52% XXX XXX XXX
EBITDA $73.9M $91.5M XXX XXX XXX
EBITDA Margin 34% 39% XXX XXX XXX
Net Profit $66.4M $57.1M XXX XXX XXX
Net Margin 31% 24% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Sido Muncul Stock Performance

As of April 15, 2025, Sido Muncul's stock price is IDR 570 (or $0).

Sido Muncul has current market cap of IDR 17.10T (or $1.0B), and EV of IDR 16.25T (or $976M).

See Sido Muncul trading valuation data

Sido Muncul Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$976M $1.0B XXX XXX XXX XXX $0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Sido Muncul Valuation Multiples

As of April 15, 2025, Sido Muncul has market cap of $1.0B and EV of $976M.

Sido Muncul's trades at 4.0x LTM EV/Revenue multiple, and 10.3x LTM EBITDA.

Analysts estimate Sido Muncul's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Sido Muncul and 10K+ public comps

Sido Muncul Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $976M XXX XXX XXX
EV/Revenue 4.1x XXX XXX XXX
EV/EBITDA 10.7x XXX XXX XXX
P/E 14.6x XXX XXX XXX
P/E/Growth 2.1x XXX XXX XXX
EV/FCF 14.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Sido Muncul Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Sido Muncul Valuation Multiples

Sido Muncul's NTM/LTM revenue growth is 7%

Sido Muncul's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $11K for the same period.

Over next 12 months, Sido Muncul's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Sido Muncul's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Sido Muncul and other 10K+ public comps

Sido Muncul Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 10% XXX XXX XXX XXX
EBITDA Margin 39% XXX XXX XXX XXX
EBITDA Growth 24% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 46% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $11K XXX XXX XXX XXX
S&M Expenses to Revenue 14% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 21% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Sido Muncul Public Comps

See public comps and valuation multiples for Nutraceuticals & Cosmeceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
SynBiotic XXX XXX XXX XXX XXX XXX
Mega Lifesciences XXX XXX XXX XXX XXX XXX
Procter & Gamble Health XXX XXX XXX XXX XXX XXX
Abbott India XXX XXX XXX XXX XXX XXX
Sanofi India XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Sido Muncul M&A and Investment Activity

Sido Muncul acquired  XXX companies to date.

Last acquisition by Sido Muncul was  XXXXXXXX, XXXXX XXXXX XXXXXX . Sido Muncul acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Sido Muncul

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Sido Muncul

When was Sido Muncul founded? Sido Muncul was founded in 1975.
Where is Sido Muncul headquartered? Sido Muncul is headquartered in Indonesia.
How many employees does Sido Muncul have? As of today, Sido Muncul has 4.4K+ employees.
Is Sido Muncul publicy listed? Yes, Sido Muncul is a public company listed on IDX.
What is the stock symbol of Sido Muncul? Sido Muncul trades under SIDO ticker.
When did Sido Muncul go public? Sido Muncul went public in 2013.
Who are competitors of Sido Muncul? Similar companies to Sido Muncul include e.g. SynBiotic, Mega Lifesciences, Procter & Gamble Health, Abbott India.
What is the current market cap of Sido Muncul? Sido Muncul's current market cap is $1.0B
What is the current revenue of Sido Muncul? Sido Muncul's last 12-month revenue is $246M.
What is the current EBITDA of Sido Muncul? Sido Muncul's last 12-month EBITDA is $94.6M.
What is the current EV/Revenue multiple of Sido Muncul? Current revenue multiple of Sido Muncul is 4.0x.
What is the current EV/EBITDA multiple of Sido Muncul? Current EBITDA multiple of Sido Muncul is 10.3x.
What is the current revenue growth of Sido Muncul? Sido Muncul revenue growth between 2023 and 2024 was 10%.
Is Sido Muncul profitable? Yes, Sido Muncul is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.